4 free views remaining today

obsolete ectopic hormone secretion syndrome associated with neoplasia

Description

Signs and Symptoms

Obsolete Ectopic Hormone Secretion Syndrome (EHSS) Associated with Neoplasia: Signs and Symptoms

Ectopic hormone secretion syndrome (EHSS) is a rare condition where abnormal cells in the body produce hormones that are not typically produced by those cells. This can lead to various signs and symptoms, which may be similar to other conditions.

Historical Context The EHSS associated with neoplasia was considered an obsolete term, but it's essential to understand its historical context. The syndrome was previously recognized as a distinct clinical entity, characterized by the secretion of hormones by non-endocrine tissues (neoplasms).

Signs and Symptoms

  • Abdominal pain and diarrhea [11]
  • Nausea, vomiting, loss of body hair, fatigue, weakness, and hypoglycemia [7]
  • Hyponatremia (dilutional) or hypernatremia (concentration), depending on the hormone involved
  • Hyperosmolality (serum) or hypoosmolality (urine)
  • Electrolyte abnormalities

Clinical Presentation The clinical presentation of EHSS associated with neoplasia can vary widely, and it's often challenging to diagnose. The symptoms may be similar to those of other conditions, making it essential to consider the possibility of EHSS in patients with unexplained hormonal imbalances.

References

  • [11] Zollinger-Ellison syndrome is a rare condition characterized by excessive secretion of gastrin, leading to peptic ulcers and diarrhea.
  • [7] A patient experiencing nausea, vomiting, loss of body hair, fatigue, weakness, and hypoglycemia may be suffering from SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion).

Please note that EHSS associated with neoplasia is an outdated term, and the current understanding of ectopic hormone secretion has evolved. The signs and symptoms listed above are based on historical references and should not be considered a comprehensive or up-to-date list of symptoms for modern medical practice.

Additional Symptoms

  • Abdominal pain and diarrhea
  • Electrolyte abnormalities
  • Nausea, vomiting, loss of body hair, fatigue, weakness, and hypoglycemia
  • Hyponatremia (dilutional) or hypernatremia (concentration)
  • Hyperosmolality (serum) or hypoosmolality (urine)

Diagnostic Tests

Treatment

Treatment Options for Ectopic Hormone Secretion Syndrome

Ectopic hormone secretion syndrome (EHSS) is a rare condition where a tumor secretes excess hormones, leading to various symptoms. While the exact treatment options may vary depending on the type of tumor and hormone involved, here are some common drug treatments used to manage EHSS:

  • Somatostatin analogs: These medications, such as octreotide and pasireotide, can help decrease hormone production in tumors like carcinoid, gastrinoma, and VIPoma [10].
  • Dopamine agonists: Medications like cabergoline and bromocriptine can be used to treat prolactinomas and other dopamine-sensitive tumors [10].
  • Everolimus: This mTOR inhibitor has been shown to be effective in treating various types of neuroendocrine tumors (NETs), including those associated with EHSS [11].
  • Temozolomide: This chemotherapy agent is used to treat NETs, including those that secrete excess hormones [11].
  • Capecitabine: Another chemotherapy medication used to treat NETs and EHSS [11].
  • Vandetanib: This targeted therapy has been approved for treating medullary thyroid cancer, which can be associated with EHSS [12].

Other Treatment Options

In addition to these drug treatments, other options may include:

  • Surgery: In some cases, surgery may be necessary to remove the tumor and alleviate symptoms.
  • Radiation therapy: This treatment option can help reduce tumor size and alleviate symptoms.

It's essential to note that each case of EHSS is unique, and the most effective treatment plan will depend on individual factors. A multidisciplinary team of healthcare professionals should work together to develop a personalized treatment strategy for patients with EHSS.

References:

[10] AD Herrera-Martínez et al. (2019). Medical treatment options for EAS include: (1) Tumor-directed drugs including somatostatin analogs (octreotide, pasireotide) and dopamine agonists that decrease hormone production in tumors like carcinoid, gastrinoma, and VIPoma.

[11] R Chacko et al. (2022). National guidelines recommend implementing treatment with chemotherapy agents such as everolimus, temozolomide, and capecitabine in patients who have failed or are not candidates for surgery.

[12] C Baudry et al. (2013). Vandetanib was recently approved to treat symptomatic or progressive medullary thyroid cancer.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis of ectopic hormone secretion syndrome associated with neoplasia involves a comprehensive evaluation to rule out various conditions that may present with similar symptoms.

  • Paraneoplastic syndromes: These are secondary signs and symptoms associated with a neoplasm, independently from the location of the primary tumor or its metastases [8]. Paraneoplastic endocrine syndromes define a group of secondary signs and symptoms associated to a neoplasia, independently from the location of the primary tumor or its metastases [8].
  • Ectopic ACTH syndrome: This is a rare condition caused by ectopic production of adrenocorticotropic hormone (ACTH) by non-pituitary tumors, leading to Cushing's syndrome. The clinical criteria for establishing the diagnosis of ectopic ACTH secretion syndrome include inadequate secretion of antidiuretic hormone and malignant hypercalcemia [5].
  • Pheochromocytoma: This is a rare tumor that produces excess catecholamines, leading to hypertension and other symptoms. Pheochromocytomas can be associated with ectopic hormone production.
  • Medullary thyroid carcinoma: This is a type of cancer that originates in the thyroid gland and can produce ectopic hormones such as ACTH or calcitonin.
  • Small-cell lung cancer (SCLC): SCLC is a type of lung cancer that can produce ectopic hormones, including ACTH.

To establish a differential diagnosis, it is essential to consider the patient's medical history, physical examination findings, laboratory results, and imaging studies. The following tests may be performed:

  • Laboratory tests: These include measurements of hormone levels in the blood or urine, such as ACTH, cortisol, and calcitonin.
  • Imaging studies: These include computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans to visualize the tumor and its metastases.
  • Endocrine tests: These may include dynamic tests performed by an endocrinologist to assess hormone production and regulation.

A thorough evaluation of these factors will help healthcare providers to establish a differential diagnosis for ectopic hormone secretion syndrome associated with neoplasia.

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:3402
core#notation
DOID:3402
oboInOwl#hasExactSynonym
neoplasm associated Ectopic Hormone Secretion syndromes
rdf-schema#label
obsolete ectopic hormone secretion syndrome associated with neoplasia
owl#deprecated
true
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10306

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.